Wednesday 11 January 2012

Impairment of Long-lived Tangible Asset Held for Use - FRA (CFA Level II)

Under IFRS:

• Impairment losses are recognized when: Carrying amount of the asset > recoverable amount of the asset
   where Recoverable amount is higher of (Fair value - Costs to sell) and Value in use.
   Value in use = discounted expected future cash flows.

• Companies are required to assess at least annually whether there are any indications of impairment of an asset.
• Goodwill and identifiable intangible assets that are not amortized must be tested for impairment at least annually.

Under U.S. GAAP:

• Under U.S. GAAP, there is a two step test which is used to determine whether the asset is impaired.
    1) Recoverability test: Asset's carrying amount is not recoverable when:
    Carrying value of the asset > Undiscounted expected future cash flows
    2) Impairment loss measurement: When asset's carrying amount is not recoverable, then
    Impairment Loss = Carrying amount of an asset - Fair value of an asset (or discounted value of
    expected future cash flows)
• Companies must undertake an impairment test only when “events or circumstances indicate that carrying value of an asset is not recoverable on permanent basis”.

• Goodwill and identifiable intangible assets that are not amortized must be tested for impairment at least annually.


Examples of indicators of impairment test include:
• Significant adverse change in asset’s physical condition,
• Significant adverse change in legal or economic factors, or
• Significant decrease in the market price among others.

Effects of Impairment loss:  
• It reduces the carrying  amount of the asset on balance sheet.
• It reduces net income on the income statement.
• Impairment loss is a non-cash item and thus, it does not affect operating cash flows.
• Debt-to-total assets and fixed asset turnover ratios increase due to impairment loss because it reduces the carrying amount of fixed assets and thus total assets




2 comments:

  1. This is a good revision for me. I like the notes

    ReplyDelete
  2. Is it normal that in the impairment loss measurement we do subtract selling cost from the fair value according to IFRS but not under USGAAP.

    Thank a lot!

    ReplyDelete